company background image
UMTA

Genertec Universal Medical Group OTCPK:UMTA.F Stock Report

Last Price

HK$0.58

Market Cap

HK$1.2b

7D

-9.4%

1Y

n/a

Updated

03 May, 2022

Data

Company Financials +
UMTA.F fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance2/6
Financial Health3/6
Dividends3/6

UMTA.F Stock Overview

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China.

Genertec Universal Medical Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genertec Universal Medical Group
Historical stock prices
Current Share PriceHK$0.58
52 Week HighHK$0.90
52 Week LowHK$0.55
Beta0.63
1 Month Change-7.94%
3 Month Change-22.67%
1 Year Changen/a
3 Year Change-22.15%
5 Year Changen/a
Change since IPO-30.04%

Recent News & Updates

Shareholder Returns

UMTA.FUS Diversified FinancialUS Market
7D-9.4%-3.0%0.4%
1Yn/a12.1%-7.0%

Return vs Industry: Insufficient data to determine how UMTA.F performed against the US Diversified Financial industry.

Return vs Market: Insufficient data to determine how UMTA.F performed against the US Market.

Price Volatility

Is UMTA.F's price volatile compared to industry and market?
UMTA.F volatility
UMTA.F Average Weekly Movementn/a
Diversified Financial Industry Average Movement6.6%
Market Average Movement7.4%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market2.8%

Stable Share Price: Insufficient data to determine UMTA.F's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine UMTA.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
198415,242Wang Wenbinghttps://www.umcare.cn

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.

Genertec Universal Medical Group Fundamentals Summary

How do Genertec Universal Medical Group's earnings and revenue compare to its market cap?
UMTA.F fundamental statistics
Market CapCN¥7.90b
Earnings (TTM)CN¥1.84b
Revenue (TTM)CN¥9.57b

4.3x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UMTA.F income statement (TTM)
RevenueCN¥9.57b
Cost of RevenueCN¥5.71b
Gross ProfitCN¥3.85b
Other ExpensesCN¥2.02b
EarningsCN¥1.84b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.97
Gross Margin40.26%
Net Profit Margin19.18%
Debt/Equity Ratio243.0%

How did UMTA.F perform over the long term?

See historical performance and comparison

Dividends

7.1%

Current Dividend Yield

30%

Payout Ratio

Valuation

Is Genertec Universal Medical Group undervalued compared to its fair value and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


37.2%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: UMTA.F ($0.58) is trading below our estimate of fair value ($0.92)

Significantly Below Fair Value: UMTA.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: UMTA.F is good value based on its PE Ratio (4.3x) compared to the US Diversified Financial industry average (7.1x).

PE vs Market: UMTA.F is good value based on its PE Ratio (4.3x) compared to the US market (16.2x).


Price to Earnings Growth Ratio

PEG Ratio: UMTA.F is good value based on its PEG Ratio (0.3x)


Price to Book Ratio

PB vs Industry: UMTA.F is good value based on its PB Ratio (0.5x) compared to the US Diversified Financial industry average (0.8x).


Future Growth

How is Genertec Universal Medical Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: UMTA.F's forecast earnings growth (16.1% per year) is above the savings rate (1.9%).

Earnings vs Market: UMTA.F's earnings (16.1% per year) are forecast to grow faster than the US market (12.9% per year).

High Growth Earnings: UMTA.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if UMTA.F's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if UMTA.F's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: UMTA.F's Return on Equity is forecast to be low in 3 years time (16.7%).


Past Performance

How has Genertec Universal Medical Group performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


13.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: UMTA.F has high quality earnings.

Growing Profit Margin: UMTA.F's current net profit margins (19.2%) are lower than last year (20%).


Past Earnings Growth Analysis

Earnings Trend: UMTA.F's earnings have grown by 13% per year over the past 5 years.

Accelerating Growth: UMTA.F's earnings growth over the past year (11.4%) is below its 5-year average (13% per year).

Earnings vs Industry: UMTA.F earnings growth over the past year (11.4%) underperformed the Diversified Financial industry 212.8%.


Return on Equity

High ROE: UMTA.F's Return on Equity (11.5%) is considered low.


Financial Health

How is Genertec Universal Medical Group's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: UMTA.F's short term assets (CN¥64.5B) exceed its short term liabilities (CN¥18.7B).

Long Term Liabilities: UMTA.F's short term assets (CN¥64.5B) exceed its long term liabilities (CN¥33.5B).


Debt to Equity History and Analysis

Debt Level: UMTA.F's net debt to equity ratio (229.7%) is considered high.

Reducing Debt: UMTA.F's debt to equity ratio has reduced from 283.1% to 243% over the past 5 years.

Debt Coverage: UMTA.F's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if UMTA.F's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Genertec Universal Medical Group current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


7.05%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: UMTA.F's dividend (7.05%) is higher than the bottom 25% of dividend payers in the US market (1.5%).

High Dividend: UMTA.F's dividend (7.05%) is in the top 25% of dividend payers in the US market (3.9%)


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, UMTA.F has been paying a dividend for less than 10 years.

Growing Dividend: UMTA.F's dividend payments have increased, but the company has only paid a dividend for 6 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (29.7%), UMTA.F's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: UMTA.F is paying a dividend but the company has no free cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.3yrs

Average management tenure


CEO

Wang Wenbing (47 yo)

5.25yrs

Tenure

Mr. Wang Wenbing has been Deputy General Manager of Genertec Universal Medical Group Company Limited (formerly known as Universal Medical Financial & Technical Advisory Services Company Limited) since Febr...


Leadership Team

Experienced Management: UMTA.F's management team is seasoned and experienced (5.3 years average tenure).


Board Members

Experienced Board: UMTA.F's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: UMTA.F insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Genertec Universal Medical Group Company Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Genertec Universal Medical Group Company Limited
  • Ticker: UMTA.F
  • Exchange: OTCPK
  • Founded: 1984
  • Industry: Specialized Finance
  • Sector: Diversified Financials
  • Implied Market Cap: HK$9.382b
  • Listing Market Cap: HK$1.196b
  • Shares outstanding: 1.89b
  • Website: https://www.umcare.cn

Number of Employees


Location

  • Genertec Universal Medical Group Company Limited
  • West Wing of Hademen Plaza
  • 4th, 5th, and 13th Floor
  • Beijing
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/03 00:00
End of Day Share Price2022/04/27 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.